Bio-Path Holdings - 53 Year Dividend History | BPTH
Historical dividend payout and yield for Bio-Path Holdings (BPTH) since 1971. The current TTM dividend payout for Bio-Path Holdings (BPTH) as of November 20, 2024 is $0.00. The current dividend yield for Bio-Path Holdings as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.002B |
$0.000B |
|
BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
